Skip to main content
Lilach Gutter-Kapon on Muck Rack

Lilach Gutter-Kapon

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lilach

Contact Lilach, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth

|
By Udayan Bhattacharya, Rappaport Faculty, Lilach Gutter-Kapon, Tal Kan
| cancerres.aacrjournals.org
Molecular Cell Biology Udayan Bhattacharya, Lilach Gutter-Kapon, Tal Kan, Ilanit Boyango, Uri Barash, Shi-Ming Yang, JingJing Liu, Miriam Gross-Cohen, Ralph D. Sanderson, Yuval Shaked, Neta Ilan and Israel Vlodavsky DOI: 10.1158/0008-5472.CAN-19-1676 Published January 2020 This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Open in Who Shared Issue with article?

Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth

|
By Udayan Bhattacharya, Rappaport Faculty, Lilach Gutter-Kapon, Tal Kan
| cancerres.aacrjournals.org
Molecular Cell Biology Udayan Bhattacharya, Lilach Gutter-Kapon, Tal Kan, Ilanit Boyango, Uri Barash, Shi-Ming Yang, JingJing Liu, Miriam Gross-Cohen, Ralph D. Sanderson, Yuval Shaked, Neta Ilan and Israel Vlodavsky DOI: 10.1158/0008-5472.CAN-19-1676 Abstract The emerging role of heparanase in tumor initiation, growth, metastasis, and chemoresistance is well recognized, encouraging the development of heparanase inhibitors as anticancer drugs.
Open in Who Shared Issue with article?

Heparanase and chemotherapy synergize to drive macrophage activation and enhance tumor growth

|
By Lilach Gutter-Kapon, Udayan Bhattacharya, Tal Kan, Ilanit Boyango
| cancerres.aacrjournals.org
Research Article Udayan Bhattacharya, Lilach Gutter-Kapon, Tal Kan, Ilanit Boyango, Uri Barash, Shi-ming Yang, JingJing Liu, Miriam Gross-Cohen, Ralph D. Sanderson, Yuval Shaked, Neta Ilan and Israel Vlodavsky DOI: 10.1158/0008-5472.CAN-19-1676 Abstract The emerging role of heparanase in tumor initiation, growth, metastasis, and chemoresistance is well recognized, encouraging the development of heparanase inhibitors as anticancer drugs.
Open in Who Shared Issue with article?
See all 4 articles